AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Drug Companies Can't Tell a Doctor, Ha, You Can Prescribe for Purpose B
The drug company, historically has not ben able to tell the doctor, ha, you can prescribe for purpose b, because that would be considered so called off label marketing. The fta hadn't approvedt that was basically most very recently, 20 18, i believe, rejected on free speech grounds in us. And so like f t a's power tocentralize drugs kind of dropped a little. O, that's another example of the decentra eestonts, not of no diagnosics, but of drus. Is that clear? Should shoul time that up for inse?